Literature DB >> 7871087

Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.

M Papp1, V Klimek, P Willner.   

Abstract

Chronic sequential exposure to a variety of mild stressors has previously been found to cause an antidepressant-reversible decrease in the consumption of palatable sweet solutions, associated with abnormalities of dopaminergic neurotransmission in the nucleus accumbens. In the present study, 5 weeks of treatment with imipramine (10 mg/kg b.i.d.) reversed the decreased sucrose intake of rats exposed to chronic mild stress. Stress also caused a decrease in D2-receptor binding in the limbic forebrain (but not the striatum), which was completely reversed by imipramine. In nonstressed animals, imipramine decreased D1-receptor binding in both regions. However, in stressed animals, imipramine did not significantly alter D1-receptor binding in either area. Stress alone slightly increased D1-receptor binding, in striatum only. Scatchard analysis showed that all changes in receptor binding resulted from changes in receptor number (Bmax) rather than receptor affinity (KD). The results support the hypothesis that changes in D2-receptor function in the nucleus accumbens are responsible for chronic mild stress-induced anhedonia and its reversal by antidepressant drugs. They do not support the hypothesis that the sensitization of D2-receptors seen following chronic antidepressant treatment is caused by a down-regulation of D1-receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871087     DOI: 10.1007/bf02245566

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Effect of desipramine on dopamine receptor binding in vivo.

Authors:  T Suhara; O Inoue; K Kobayasi
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

2.  Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress.

Authors:  M Papp; S Lappas; R Muscat; P Willner
Journal:  J Psychopharmacol       Date:  1992-01       Impact factor: 4.153

3.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Repeated treatment with antidepressant drugs potentiates the locomotor response to (+)-amphetamine.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

5.  Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

Authors:  M Papp; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  The influence of oxaprotiline enantiomers given repeatedly on the behavioural effects of d-amphetamine and dopamine injected into the nucleus accumbens.

Authors:  J Maj; K Wedzony
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

7.  Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.

Authors:  M T Martin-Iverson; J F Leclere; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

8.  Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

Authors:  J A Stamford; R Muscat; J J O'Connor; J Patel; S J Trout; W J Wieczorek; Z L Kruk; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Effects of moclobemide, a new generation reversible Mao-A inhibitor, in a novel animal model of depression.

Authors:  J L Moreau; F Jenck; J R Martin; P Mortas; W Haefely
Journal:  Pharmacopsychiatry       Date:  1993-01       Impact factor: 5.788

10.  Down-regulation of dopamine1 (D1) receptors by chronic imipramine is species-specific.

Authors:  G Nowak; P Skolnick; I A Paul
Journal:  Pharmacol Biochem Behav       Date:  1991-07       Impact factor: 3.533

View more
  41 in total

Review 1.  The addicted human brain: insights from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  Neurobiology of chronic mild stress: parallels to major depression.

Authors:  Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2012-07-07       Impact factor: 8.989

Review 3.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

4.  Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats.

Authors:  Naila Rasheed; Ausaf Ahmad; Chandra Prakash Pandey; Rajnish Kumar Chaturvedi; Mohtashim Lohani; Gautam Palit
Journal:  Neurochem Res       Date:  2009-07-01       Impact factor: 3.996

5.  The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice.

Authors:  Or Burstein; Ravid Doron
Journal:  J Vis Exp       Date:  2018-10-24       Impact factor: 1.355

6.  Polybrominated diphenyl ether (PBDE) and poly- and perfluoroalkyl substance (PFAS) exposures during pregnancy and maternal depression.

Authors:  Ann M Vuong; Kimberly Yolton; Joseph M Braun; Andreas Sjodin; Antonia M Calafat; Yingying Xu; Kim N Dietrich; Bruce P Lanphear; Aimin Chen
Journal:  Environ Int       Date:  2020-04-05       Impact factor: 9.621

7.  Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer.

Authors:  S Cheeta; C Broekkamp; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

8.  Dopamine receptor alterations in female rats with diet-induced decreased brain docosahexaenoic acid (DHA): interactions with reproductive status.

Authors:  Paul F Davis; Marlies K Ozias; Susan E Carlson; Gregory A Reed; Michelle K Winter; Kenneth E McCarson; Beth Levant
Journal:  Nutr Neurosci       Date:  2010-08       Impact factor: 4.994

9.  N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment.

Authors:  Beth Levant
Journal:  Depress Res Treat       Date:  2010-10-27

10.  Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Authors:  Dara M Cannon; Jacqueline M Klaver; Summer A Peck; Denise Rallis-Voak; Kristine Erickson; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.